Log in to search using one of your social media accounts:

 

Tdap Vaccine Safe for Mother, Fetus

TUESDAY, Nov. 1, 2016 -- The Tdap (tetanus, diphtheria and pertussis) vaccine is safe for pregnant women who hope to pass their immunity on to their newborns, a new study shows. The vaccine does not appear to cause birth defects or any other major...
Source: Drugs.com - Daily MedNews - Category: Journals (General) Source Type: news

Related Links:

Conclusions: The present results indicate a blunting effect after primary vaccination for some serotypes resolving after booster vaccination. Seroprotection rates were comparable both after primary and booster vaccination, except for serotype 3 with a significant lower seroprotection rate in the vaccine group after primary vaccination.
Source: The Pediatric Infectious Disease Journal - Category: Infectious Diseases Tags: Vaccine Reports Source Type: research
Purpose of review: Maternal vaccination is a well-tolerated and effective way to protect mothers, their developing fetuses, and their young infants from infectious diseases. Although influenza vaccine and diphtheria, tetanus, and acellular pertussis (Tdap) vaccine are recommended for all pregnant women, uptake rates in the United States remain low. This review will focus on the rationale, scientific evidence, and perceptions of vaccination during pregnancy. Recent findings: Recent studies show that administration of influenza and Tdap vaccines during pregnancy is well tolerated and provides protection to the pregnant woma...
Source: Current Opinion in Pediatrics - Category: Pediatrics Tags: OFFICE PEDIATRICS: Edited by Henry H. Bernstein Source Type: research
Abstract OBJECTIVE: To study characteristics and preventive interventions of adult pregnant and breastfeeding travelers seeking pretravel health care in the United States. METHODS: This cross-sectional study analyzed data (2009-2014) of pregnant and breastfeeding travelers seen at U.S. travel clinics participating in Global TravEpiNet. Nonpregnant, nonbreastfeeding adult female travelers of childbearing age were used for comparison. We evaluated the prescription of malaria chemoprophylaxis and antibiotics for this population as well as the administration of three travel-related vaccines: hepatitis A, typhoid,...
Source: Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Obstet Gynecol Source Type: research
(Abstracted from Pediatrics 2017;139(5):e20164091) Pertussis is a virulent and life-threatening respiratory infection, particularly in infants, caused by the bacteria Bordetella pertussis. Tetanus toxoid, reduced diphtheria toxoid, acellular pertussis (TDaP) vaccination during pregnancy is recommended to protect newborns against pertussis.
Source: Obstetrical and Gynecological Survey - Category: OBGYN Tags: Obstetrics: Preconception and Prenatal Care Source Type: research
Abstract Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is recommended during the third trimester of each pregnancy to provide protection to newborns, who are at risk for pertussis-related morbidity and mortality (1). As part of its case-control surveillance study of medications and birth defects, the Birth Defects Study of the Slone Epidemiology Center at Boston University (the Birth Defects Study) has recorded data on vaccinations received during pregnancy since 2006. Among 5,606 mothers of infants without structural birth defects in this population (control group),
Source: MMWR Morb Mortal Wkl... - Category: Epidemiology Authors: Tags: MMWR Morb Mortal Wkly Rep Source Type: research
A CDC study estimated that vaccinating pregnant women with the tetanus, diphtheria and acellular pertussis vaccine during their third trimester was nearly 78 percent effective in preventing pertussis in their infants younger than 2 months.
Source: AAFP News - Category: Primary Care Source Type: news
Timely vaccination can prevent three-quarters of cases in newborns Source: HealthDay Related MedlinePlus Pages: Infections and Pregnancy, Tetanus, Diphtheria, and Pertussis Vaccines, Whooping Cough
Source: MedlinePlus Health News - Category: Consumer Health News Source Type: news
Authors: Abstract The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leaves a window of significant vulnerability for newborns, many of whom contract serious pertussis infections from family members and caregivers, especially their mothers, or older siblings, or both. In 2013, the Advisory Committee on Immunization Practices published its updated recommendation that a dose of tetanus toxoid, reduced diphtheria toxoid, and ac...
Source: Obstetrics and Gynecology - Category: OBGYN Tags: Obstet Gynecol Source Type: research
Conclusions: These results are in accord with previous findings of PFAS immunotoxicity at current exposure levels. https://doi.org/10.1289/EHP275 Received: 09 February 2016 Revised: 06 June 2016 Accepted: 12 July 2016 Published: 26 July 2017 Address correspondence to P. Grandjean, HSPH-EOME, 401 Park Dr., 3E L3-045, Boston, MA 02215 USA. Telephone: 617-384-8907. Email: pgrandjean@health.sdu.dk The authors declare they have no actual or potential competing financial interests. Note to readers with disabilities: EHP strives to ensure that all journal content is accessible to all readers. However, some figure...
Source: EHP Research - Category: Environmental Health Authors: Tags: Research Source Type: research
Abstract Many countries recommend combined tetanus toxoid, reduced diphtheria toxoid and acellular pertussis immunization (Tdap) during pregnancy to stimulate transplacental transmission of pertussis antibodies to newborns. The immune system can be altered during pregnancy, potentially resulting in differing immunization risks in pregnant women. The safety of widespread Tdap immunization during pregnancy needs to be established. Our objective was to assess whether prenatal Tdap immunization was associated with adverse birth outcomes, and to evaluate the effect of timing of Tdap administration on these outcomes. We...
Source: Vaccine - Category: Allergy & Immunology Authors: Tags: Vaccine Source Type: research
More News: Diphtheria | General Medicine | Pregnancy | Study | Tetanus | Tetanus Diptheria Pertussis Vaccine Tdap,Dtap,Dpt | Tetanus Vaccine | Vaccines | Whooping Cough (Pertussis) Vaccine | Women